Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KORU vs GSK✓SelectedUSD · GSKKORU vs GSK performance historyLatest closeAs of-25.04%11/20
Stock and ETF performance explorer

KORU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+22.5%
GSK return
+53.4%
Excess return
-30.8%
Maximum drawdown
-92.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-25.0%-0.1%-24.9%-25.0%
7D-38.0%-5.3%-32.7%-37.7%
30D-60.1%-3.7%-56.5%-60.0%
3M-76.6%-7.3%-69.3%-76.3%
6M-87.5%-4.2%-83.2%-87.7%
YTD-47.6%+0.9%-48.4%-49.1%
1Y-27.8%+7.3%-35.0%-31.7%
3Y+22.5%+52.7%-30.2%-5.1%
All+22.5%+53.4%-30.8%-5.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling